Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Science 269 , 230234 (1995)
Contrave is FDA-approved for chronic weight management in adults with a BMI of 30 or higher (obesity), or a BMI of 27 or higher with at least one weight-related condition such as type 2 diabetes, high blood pressure, or high cholesterol
Intervention The following GLP-1 RAs were included in this study: albiglutide, dulaglutide, exenatide, liraglutide, lixisenatide, and semaglutide
All findings are from animal studies no human clinical trials have been completed
US$ 26.45
US$ 28.29
US$ 24.39
US$ 21.62
US$ 25.94
US$ 26.29
US$ 24.96
